Stringent Regulatory Authorities (SRAs) are national drug Regulatory bodies listed and recognized by the World health Organization (WHO), who are responsible for applying rigorous standards when reviewing and approving drugs/vaccines. The stringent standards set by SRAs focus on the following three (03) key aspects:
- Quality: SRAs ensure that drugs are manufactured according to established quality control procedures to guarantee their purity, potency, and consistency.
- Safety: SRAs mandate extensive clinical trials to assess potential risks and side effects of new drugs before they are marketed.
- Efficacy: SRAs meticulously evaluate the data demonstrating a drug’s efficacy in treating the intended condition(s).
How are SRAs Identified?
SRAs are identified based on two (02) main criteria, which are:
- Membership in the International Council for Harmonisation (ICH): The ICH brings together Regulatory authorities from the European Union (EU), United States (US), and Japan to establish a unified approach for pharmaceutical development and registration.
- WHO Designation: The WHO maintains a list of SRAs, based on their evaluation of the particular authority’s procedures and adherence to international quality standards.
The Importance of SRAs in the Pharmaceutical Industry
SRAs play a critical role in the pharmaceutical industry, as their regulations help:
- Minimize Health Risks: Rigorous testing procedures adopted by SRAs reduce the chances of unsafe or ineffective products reaching the market.
- Promote Innovation: Clear, consistent regulations set by SRAs provide a framework for pharmaceutical companies to develop new and effective treatments.
- Facilitating Global Access: Approval by an SRA can streamline the process for a drug to be marketed in other countries with similar Regulatory requirements.
Thus, SRAs are essential for building a pharmaceutical landscape that prioritizes patient safety while fostering innovation. Speak to our expert today to learn how Freyr can help you seamlessly navigate the realm of SRAs.